Zachary Zavodni
Ophthalmology · Salt Lake City, UTNPI 1235371469
Payments from drug & device makers
Across 893 payments — averaging $1220.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$1M
- Glaukos Corporation$34K
- Alcon$15K
- Beaver-visitec International, Inc.$10K
- Johnson & Johnson Surgical Vision, Inc.$2K
- AbbVie$241
- plus $783 from 14 others
Across 1 payment — averaging $49,430 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beaver-visitec International, Inc.$49K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 783 | $1,029,256 |
| Glaukos Corporation | 26 | $34,068 |
| Alcon | 47 | $14,580 |
| Beaver-visitec International, Inc. | 1 | $9,740 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $1,500 |
| AbbVie(2 entities) | 13 | $241 |
| Rayner Intraocular Lenses Limited | 1 | $154 |
| Kala Pharmaceuticals, Inc. | 2 | $127 |
| Novartis | 2 | $92 |
| Ocular Therapeutix, Inc. | 1 | $80 |
| Biotissue Holdings Inc. | 3 | $79 |
| Hoffmann-la Roche Limited | 1 | $46 |
| Dompe US, Inc. | 2 | $39 |
| Aerie Pharmaceuticals, Inc. | 2 | $36 |
| Bausch & Lomb Americas Inc. | 2 | $36 |
| Rxsight Inc | 2 | $27 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $22 |
| Carl Zeiss Meditec USA, Inc. | 1 | $18 |
| Omeros Corporation | 1 | $15 |
| Lensar, Inc. | 1 | $13 |
How this compares
$1,090,167 in reported general payments places this provider in the 95th percentile of 191 ophthalmology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Salt Lake City
- Majid MoshirfarSalt Lake City$1.4M
- Iqbal AhmedSalt Lake City$1.1M
- Paul BernsteinSalt Lake City$354K
- Craig ChayaSalt Lake City$234K
- Robert CionniSalt Lake City$191K
- Kristin BretzSalt Lake City$175K
- Stacy SmithSalt Lake City$166K
- Marc Steffen Schmitz-ValckenbergSalt Lake City$160K
- Rachel SimpsonSalt Lake City$135K
- Rachael JacobySalt Lake City$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.